Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2011 (2011), Article ID 561396, 8 pages
http://dx.doi.org/10.1093/ecam/neq028
Original Article

The Roles of Buyang Huanwu Decoction in Anti-Inflammation, Antioxidation and Regulation of Lipid Metabolism in Rats with Myocardial Ischemia

1Department of Pharmacology, Medical School of Xi’an Jiaotong University, Xi’an, Shaanxi 710068, China
2Shaanxi Provincial People’s Hospital, Xi’an, Shaanxi 710068, China

Received 30 September 2009; Accepted 11 March 2010

Copyright © 2011 Yu Liu et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. K. Kuwabara, Y. Imanaka, S. Matsuda et al., “Impact of age and procedure on resource use for patients with ischemic heart disease,” Health Policy, vol. 85, no. 2, pp. 196–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  2. N. W. Shammas and E. Dippel, “Inflammation and cardiovascular risk: an overview,” International Journal of Angiology, vol. 13, no. 4, pp. 161–167, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. F. Lombardi, F. Tundo, P. Terranova et al., “Prognostic value of C-reactive protein in patients with stress induced myocardial ischemia,” International Journal of Cardiology, vol. 98, no. 2, pp. 313–317, 2005. View at Publisher · View at Google Scholar · View at Scopus
  4. J. Suzuki, M. Ogawa, Y. Maejima et al., “Tea catechins attenuate chronic ventricular remodeling after myocardial ischemia in rats,” Journal of Molecular and Cellular Cardiology, vol. 42, pp. 432–440, 2007. View at Google Scholar
  5. E. Lutgens and M. J. A. P. Daemen, “CD40-CD40L interactions in atherosclerosis,” Trends in Cardiovascular Medicine, vol. 12, no. 1, pp. 27–32, 2002. View at Publisher · View at Google Scholar · View at Scopus
  6. L. Molero, A. López-Farré, P. J. Mateos-Cáceres et al., “Effect of clopidogrel on the expression of inflammatory markers in rabbit ischemic coronary artery,” British Journal of Pharmacology, vol. 146, pp. 419–424, 2005. View at Google Scholar
  7. H. Zhang, M. J. Liang, and Z. X. Ma, “Clinical study on effects of buyang huanwu decoction on coronary heart disease,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 15, no. 4, pp. 213–215, 1995. View at Google Scholar · View at Scopus
  8. H. B. Tan, Q. He, S. Y. Zhao, and J. N. Wang, “Experimental and clinical studies on cardiovascular disease of buyang huanwu decoction,” Journal of Misdiagnostics, vol. 5, pp. 3226–3228, 2005. View at Google Scholar
  9. J. Zhang, J. L. Chen, Q. Gu, T. Guan, and X. Chen, “Effects of inhibition of CD40-CD40 ligand system on atherosclerosis,” Chinese Journal of Arteriosclerosis, vol. 14, pp. 119–121, 2006 (Chinese). View at Google Scholar
  10. Y. L. Zhao and Y. Z. Qu, “The effect of buyanghuanwu decoction and the separate component on the level of IL-6 in brain tissue in rats after cerebral ischemia,” JETCM, vol. 16, pp. 198–199, 2007 (Chinese). View at Google Scholar
  11. G. D. Yang, Z. Y. Fang, Y. Liu et al., “Protective effects of Chinese traditional medicine buyang huanwu decoction on myocardial injury,” Evidence-Based Complementary and Alternative Medicine. In press. View at Publisher · View at Google Scholar
  12. L. V. Ravichandran, R. Puvanakrishnan, and K. T. Joseph, “Influence of isoproterenol-induced myocardial infarction on certain glycohydrolases and cathepsins in rats,” Biochemical Medicine and Metabolic Biology, vol. 45, no. 1, pp. 6–15, 1991. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Feng, D. Meng, X.-J. Chen, D. Yang, and J.-N. Zhang, “Protective action of astragalosides on myocardial injury induced by isoproterenol in rats,” Chinese Pharmaceutical Journal, vol. 41, no. 17, pp. 1313–1316, 2006. View at Google Scholar · View at Scopus
  14. T. O. Cheng, “Danshen: a versatile Chinese herbal drug for the treatment of coronary heart disease,” International Journal of Cardiology, vol. 113, no. 3, pp. 437–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. X.-J. Chen, D. Meng, L. Feng et al., “Protective effect of astragalosides on myocardial injury by isoproterenol in SD rats,” American Journal of Chinese Medicine, vol. 34, no. 6, pp. 1015–1025, 2006. View at Publisher · View at Google Scholar · View at Scopus
  16. Y. R. Shi, D. F. Bu, Y. F. Qi et al., “Dysfunction of myocardial taurine transport and effect of taurine supplement in rats with isoproterenol-induced myocardial injury,” Acta Pharmacologica Sinica, vol. 23, pp. 910–918, 2002. View at Google Scholar
  17. R. Lin, J. Liu, W. Gan, and G. Yang, “C-reactive protein-induced expression of CD40-CD40L and the effect of lovastatin and fenofibrate on it in human vascular endothelial cells,” Biological and Pharmaceutical Bulletin, vol. 27, no. 10, pp. 1537–1543, 2004. View at Publisher · View at Google Scholar · View at Scopus
  18. Z.-Y. Fang, R. Lin, B.-X. Yuan, G.-D. Yang, Y. Liu, and H. Zhang, “Tanshinone IIA downregulates the CD40 expression and decreases MMP-2 activity on atherosclerosis induced by high fatty diet in rabbit,” Journal of Ethnopharmacology, vol. 115, no. 2, pp. 217–222, 2008. View at Publisher · View at Google Scholar · View at Scopus
  19. P. Vanichakarn, P. Blair, C. Wu, J. E. Freedman, and S. Chakrabarti, “Neutrophil CD40 enhances platelet-mediated inflammation,” Thrombosis Research, vol. 122, no. 3, pp. 346–358, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. P. Aukrust, J. K. Damas, and N. O. Solum, “Soluble CD40 ligand and platelets: self-perpetuating pathogenic loop in thrombosis and inflammation?” Journal of the American College of Cardiology, vol. 43, no. 12, pp. 2326–2328, 2004. View at Publisher · View at Google Scholar · View at Scopus
  21. C. D. Garlichs, S. Eskafi, D. Raaz et al., “Patients with acute coronary syndromes express enhanced CD40 ligand/CD 154 on platelets,” Heart, vol. 86, no. 6, pp. 649–655, 2001. View at Google Scholar · View at Scopus
  22. J. C. Yan, Z. G. Wu, X. T. Kong, R. Q. Zong, and L. Z. Zhan, “Relation between upregulation of CD40 system and complex stenosis morphology in patients with acute coronary syndrome,” Acta Pharmacologica Sinica, vol. 25, pp. 251–256, 2004. View at Google Scholar
  23. D. Tanne, M. Haim, U. Goldbourt et al., “CD40 ligand and risk of ischemic stroke or coronary events in patients with chronic coronary heart disease,” International Journal of Cardiology, vol. 107, no. 3, pp. 322–326, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. M. H. Tayebjee, G. Y. H. Lip, K. T. Tan, J. V. Patel, E. A. Hughes, and R. J. MacFadyen, “Plasma matrix metalloproteinase-9, tissue inhibitor of metalloproteinase-2, and CD40 ligand levels in patients with stable coronary artery disease,” American Journal of Cardiology, vol. 96, no. 3, pp. 339–345, 2005. View at Publisher · View at Google Scholar · View at Scopus
  25. S. Türker, S. Güneri, B. Akdeniz et al., “Usefulness of preprocedural soluble CD40 ligand for predicting restenosis after percutaneous coronary intervention in patients with stable coronary artery disease,” American Journal of Cardiology, vol. 97, pp. 198–202, 2006. View at Google Scholar
  26. Y. Ohashi, S. Kawashima, T. Mori et al., “Soluble CD40 ligand and interleukin-6 in the coronary circulation after acute myocardial infarction,” International Journal of Cardiology, vol. 112, pp. 52–58, 2006. View at Google Scholar
  27. D. Tousoulis, C. Antoniades, A. Nikolopoulou et al., “Interaction between cytokines and sCD40L in patients with stable and unstable coronary syndromes,” European Journal of Clinical Investigation, vol. 37, pp. 623–628, 2007. View at Google Scholar
  28. S. H. Han, K. K. Koh, M. J. Quon, Y. Lee, and E. K. Shin, “The effects of simvastatin, losartan, and combined therapy on soluble CD40 ligand in hypercholesterolemic, hypertensive patients,” Atherosclerosis, vol. 190, no. 1, pp. 205–211, 2007. View at Publisher · View at Google Scholar · View at Scopus
  29. Z. Q. Zhang, “Effect of buyanghuanwu decoction on sICAM1 and sVSAM1 in serum in stroke patients,” New Journal of Traditional Chinese Medicine, vol. 38, pp. 17–18, 2006 (Chinese). View at Google Scholar
  30. M. Remskar, H. Li, K.-Y. Chyu, P. K. Shah, and B. Cercek, “Absence of CD40 signaling is associated with an increase in intimal thickening after arterial injury,” Circulation Research, vol. 88, no. 4, pp. 390–394, 2001. View at Google Scholar · View at Scopus
  31. A. Zirlik, C. Maier, N. Gerdes et al., “CD40 ligand mediates inflammation independently of CD40 by interaction with Mac-1,” Circulation, vol. 115, no. 12, pp. 1571–1580, 2007. View at Publisher · View at Google Scholar · View at Scopus
  32. Y. Wu and L. Jiang, “Clinical study on influence of buyang huanwu decoction on the metabolic imbalance of endothelin and calcitonin gene related peptide in patients with early cerebral infarction,” Chinese Journal of Integrative Medicine, vol. 6, pp. 112–115, 2000. View at Google Scholar
  33. A. Chen, H. Wang, J. W. Zhang et al., “BYHWD rescues axotomized neurons and promotes functional recovery after spinal cord injury in rats,” Journal of Ethnopharmacology, vol. 117, pp. 451–456, 2008. View at Google Scholar
  34. L. Wei and S. Ding, “Therapeutic effect of improved buyang huanwu decoction (decocted in wine) on coronary artery disease,” Journal of Shandong University of Traditional Chinese Medicine, vol. 26, pp. 372–474, 2002. View at Google Scholar
  35. W. B. Han, “Treatment of 60 cases of angina with improved buyang huanwu decoction,” Journal of Practical Traditional Chinese Internal Medicine, vol. 21, pp. 48–49, 2007. View at Google Scholar
  36. F. Zeng, “Application of buyang huanwu decoction in cardiovascular and peripheral vascular disease,” Journal of Practical Traditional Chinese Internal Medicine, vol. 21, pp. 66–67, 2007. View at Google Scholar
  37. R. Lin, W. R. Wang, J. T. Liu, G. D. Yang, and C. J. Han, “Protective effect of tanshinone IIA on human umbilical vein endothelial cell injured by hydrogen peroxide and its mechanism,” Journal of Ethnopharmacology, vol. 108, pp. 217–222, 2006. View at Google Scholar
  38. L. G. Chen, Y. Qu, H. Y. Ge, X. Q. Hu, Y. A. Nie, and M. Q. He, “Effect of buyang huanwu decoction on expression of adhesion molecules in vascular endothelial cells of blood stasis rats,” Chinese Traditional and Herbal Drugs, vol. 36, pp. 706–709, 2005 (Chinese). View at Google Scholar
  39. Y. H. Tang, H. Li, and B. Y. Chen, “Effect of active fraction of buyang huanwu decoction on caspase expression in rats after focal cerebral ischemic reperfusion,” Zhongguo Zhong Xi Yi Jie He Za Zhi, vol. 26, pp. 533–537, 2006. View at Google Scholar
  40. V. Lakshminarayanan, E. A. Drab-Weiss, and K. A. Roebuck, “H2O2 and tumor necrosis factor-alpha induce differential binding of the redox-responsive transcription factors AP-1 and NF-kappaB to the interleukin-8 promoter in endothelial and epithelial cells,” The Journal of Biological Chemistry, vol. 273, pp. 32670–32678, 1998. View at Google Scholar
  41. P. Gosset, B. Wallaert, A. B. Tonnel, and C. Fourneau, “Thiol regulation of the production of TNFalpha, IL-6 and IL-8 by human alveolar macrophages,” European Respiratory Journal, vol. 14, pp. 98–105, 1999. View at Google Scholar
  42. N. P. Visavadiya and A. V. R. L. Narasimhacharya, “Asparagus root regulates cholesterol metabolism and improves antioxidant status in hypercholesteremic rats,” Evidence-Based Complementary and Alternative Medicine, vol. 6, no. 2, pp. 219–226, 2009. View at Publisher · View at Google Scholar · View at Scopus
  43. F. J. Miller Jr., D. D. Gutterman, C. D. Rios, D. D. Heistad, and B. L. Davidson, “Superoxide production in vascular smooth muscle contributes to oxidative stress and impaired relaxation in atherosclerosis,” Circulation Research, vol. 82, no. 12, pp. 1298–1305, 1998. View at Google Scholar · View at Scopus
  44. A. Ranjbar, S. Khorami, M. Safarabadi et al., “Antioxidant activity of Iranian Echium amoenum Fisch & C.A. Mey flower decoction in humans: a cross-sectional before/after clinical trial,” Evidence-Based Complementary and Alternative Medicine, vol. 3, no. 4, pp. 469–473, 2006. View at Publisher · View at Google Scholar · View at Scopus
  45. T. M. Scarabelli, A. Stephanou, E. Pasini et al., “Minocycline inhibits caspase activation and reactivation, increases the ratio of XIAP to smac/DIABLO, and reduces the mitochondrial leakage of cytochrome C and smac/DIABLO,” Journal of the American College of Cardiology, vol. 43, no. 5, pp. 865–874, 2004. View at Publisher · View at Google Scholar · View at Scopus
  46. J. Yuan, J. Wu, Z. G. Hang, X. K. Zhong, L. W. Zhou, and B. Yu, “Role of peroxisome proliferator-activated receptor alpha activation in acute myocardial damage induced by isoproterenol in rats,” Chinese Medical Journal, vol. 121, pp. 1569–1573, 2008. View at Google Scholar
  47. J. A. Madrazo and D. P. Kelly, “The PPAR trio: regulators of myocardial energy metabolism in health and disease,” Journal of Molecular and Cellular Cardiology, vol. 44, no. 6, pp. 968–975, 2008. View at Publisher · View at Google Scholar · View at Scopus
  48. H. O. Steinberg, G. Paradisi, G. Hook, K. Crowder, J. Cronin, and A. D. Baron, “Free fatty acid elevation impairs insulin-mediated vasodilation and nitric oxide production,” Diabetes, vol. 49, no. 7, pp. 1231–1238, 2000. View at Google Scholar · View at Scopus
  49. M. F. Oliver, “Sudden cardiac death: the lost fatty acid hypothesis,” QJM, vol. 99, no. 10, pp. 701–709, 2006. View at Publisher · View at Google Scholar · View at Scopus
  50. D. Mozaffarian, “Trans fatty acids—effects on systemic inflammation and endothelial function,” Atherosclerosis Supplements, vol. 7, no. 2, pp. 29–32, 2006. View at Publisher · View at Google Scholar · View at Scopus
  51. A. Leaf, “Plasma nonesterified fatty acid concentration as a risk factor for sudden cardiac death: the Paris prospective study,” Circulation, vol. 104, no. 7, pp. 744–745, 2001. View at Google Scholar · View at Scopus
  52. C. Hoppel, “The role of carnitine in normal and altered fatty acid metabolism,” American Journal of Kidney Diseases, vol. 41, no. 4, pp. S4–S12, 2003. View at Google Scholar · View at Scopus